Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Interest Expenses (2023 - 2025)

Historic Interest Expenses for Arcus Biosciences (RCUS) over the last 3 years, with Q3 2025 value amounting to $3.0 million.

  • Arcus Biosciences' Interest Expenses rose 20000.0% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 30000.0%. This contributed to the annual value of $4.0 million for FY2024, which is 10000.0% up from last year.
  • Latest data reveals that Arcus Biosciences reported Interest Expenses of $3.0 million as of Q3 2025, which was up 20000.0% from $2.0 million recorded in Q2 2025.
  • Arcus Biosciences' Interest Expenses' 5-year high stood at $3.0 million during Q3 2025, with a 5-year trough of $1.0 million in Q3 2023.
  • Moreover, its 3-year median value for Interest Expenses was $1.0 million (2023), whereas its average is $1.6 million.
  • As far as peak fluctuations go, Arcus Biosciences' Interest Expenses changed by 0.0% in 2024, and later skyrocketed by 20000.0% in 2025.
  • Over the past 3 years, Arcus Biosciences' Interest Expenses (Quarter) stood at $1.0 million in 2023, then soared by 100.0% to $2.0 million in 2024, then surged by 50.0% to $3.0 million in 2025.
  • Its Interest Expenses was $3.0 million in Q3 2025, compared to $2.0 million in Q2 2025 and $1.0 million in Q1 2025.